Applied Therapeutics, Inc.: Stock Price Movements and Biopharmaceutical Advances
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical firm, is making significant strides in developing therapies for central nervous system (CNS) rare diseases and diabetic complications. Established on January 20, 2016, by Shoshana Shendelman, the company operates out of its headquarters in New York, NY, and is focused on delivering innovative treatments aimed at addressing critical unmet medical needs.
Market Performance Overview
On the trading front, Applied Therapeutics, Inc. opened at $1.11 per share, with its stock fluctuating between $1.0810 and $1.1700 throughout the trading day. Over the past 52 weeks, the company’s stock has ranged from a low of $1.0810 to a high of $10.6237. As of the latest market update, the company has a market capitalization of $133.81 million.
Corporate Structure and Financial Metrics
The firm has 116.36 million shares outstanding, with a public float of 87.26 million shares. Applied Therapeutics has maintained a beta value of 1.24, indicating a moderate level of market volatility relative to broader indexes. The company generates approximately $399,720 in revenue per employee, reflecting its operational efficiency despite being in the research-intensive biotech sector.
Research and Development Focus
Applied Therapeutics concentrates on developing a robust pipeline of therapeutic products aimed at CNS disorders and diabetic complications. By leveraging cutting-edge research and proprietary technologies, the company is working to address diseases with limited or no existing treatment options. Its research initiatives emphasize both scientific innovation and a commitment to patient-centric solutions.
Commitment to Future Growth
The company’s strategic approach focuses on advancing its drug candidates through clinical trials while forming strategic partnerships to accelerate product development. With a dedicated team of scientists and industry experts, Applied Therapeutics is well-positioned to make a lasting impact on the treatment landscape for rare and debilitating conditions.
Applied Therapeutics, Inc. continues to build a strong foundation for future growth by investing in groundbreaking medical research and pursuing potential collaborations in the biopharmaceutical industry. Its mission remains clear: to bring life-changing therapies to patients in need, enhancing their quality of life through medical innovation.
